AAAAAA

   
Results: 1-7 |
Results: 7
MORPHOGENESIS IN ACETABULARIA - BLUE-LIGHT AND CALCIUM ARE REQUIRED BUT THE NUCLEUS IS NOT
Authors: KRATZ R VONDASSOW M MANDOLI DF
Citation: R. Kratz et al., MORPHOGENESIS IN ACETABULARIA - BLUE-LIGHT AND CALCIUM ARE REQUIRED BUT THE NUCLEUS IS NOT, Developmental biology (Print), 198(1), 1998, pp. 377-377
EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I ON PROGRESSION OF ALS - A PLACEBO-CONTROLLED STUDY
Authors: LAI EC FELICE KJ FESTOFF BW GAWEL MJ GELINAS DF KRATZ R MURPHY MF NATTER HM NORRIS FH RUDNICKI SA
Citation: Ec. Lai et al., EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I ON PROGRESSION OF ALS - A PLACEBO-CONTROLLED STUDY, Neurology, 49(6), 1997, pp. 1621-1630
RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I IN ALS - DESCRIPTION OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: LANGE DJ FELICE KJ FESTOFF BW GAWEL MJ GELINAS DF KRATZ R LAI EC MURPHY MF NATTER HM NORRIS FH RUDNICKI S
Citation: Dj. Lange et al., RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I IN ALS - DESCRIPTION OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Neurology, 47(4), 1996, pp. 93-94
EVALUATION OF THE TREATMENT EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR ON HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: KRATZ R FELICE K GAWEL M GELINAS D LAI EC LANGE DJ NATTER HM RUDNICKI SA MILLER K MURPHY MF
Citation: R. Kratz et al., EVALUATION OF THE TREATMENT EFFECT OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR ON HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 46(2), 1996, pp. 63003-63003
AMYOTROPHIC-LATERAL-SCLEROSIS DISEASE PROGRESSION IN A HISTORICAL DATABASE GROUP ACCURATELY REFLECTS THE RATE OF DECLINE OF PLACEBO CONTROLS IN A PHASE-III CLINICAL-TRIAL FOR INSULIN-LIKE GROWTH-FACTOR
Authors: LAI EC FELICE K GAWEL M GELINAS D KRATZ R LANGE DJ NATTER HM RUDNICKI SA MILLER K MURPHY MF APPEL V HAVERKAMP LJ APPEL SH
Citation: Ec. Lai et al., AMYOTROPHIC-LATERAL-SCLEROSIS DISEASE PROGRESSION IN A HISTORICAL DATABASE GROUP ACCURATELY REFLECTS THE RATE OF DECLINE OF PLACEBO CONTROLS IN A PHASE-III CLINICAL-TRIAL FOR INSULIN-LIKE GROWTH-FACTOR, Neurology, 46(2), 1996, pp. 64003-64003
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR LIN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: LAI EC FELICE K FESTOFF BW GAWEL M GELINAS D KRATZ R LANGE DJ MURPHY MF NATTIER HM RUDNICKI SA
Citation: Ec. Lai et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR LIN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 38(6), 1995, pp. 2-2
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MYOTROPHIN (CEP-151) IN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: MURPHY MF FELICE K GAWEL M GELINAS D KRATZ R LAI E LANGE D NATTER H RUDNICKI S
Citation: Mf. Murphy et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MYOTROPHIN (CEP-151) IN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 38(2), 1995, pp. 335-335
Risultati: 1-7 |